News
- REGiMMUNE appoints new board members
- RGI-2001 was granted Orphan Drug Designation from FDA
- REGiMMUNE Closed Second Tranche of Private Placement
- REGiMMUNE Appoints a new board member
- REGiMMUNE Initiates Phase I/II Clinical Trial for GvHD Company Raises 5 Million Dollars in Series A Preferred to Fund Trial
- reVax patent has been granted
- Publication of GvHD paper
- REGiMMUNE Presents New ToleroVax Data at the 2010 American Transplant Congress
- About Press release from RIKEN
- “REGiMMUNE to file IND of its Tolerance Inducing therapy” : An article is on Nikkei Business Paper today
